(Approval lapsed) Apo-Pindolol 5mg tablets (Canada)
Section 19A approved medicine
(Approval lapsed) Apo-Pindolol 5mg tablets (Canada)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
BARBLOC 5 pindolol 5mg tablet bottle - ARTG 17589
Indication(s)
- Management of hypertension (either alone or in combination with other anti-hypertensive drugs)
- Management of angina pectoris (prevention of attacks).
- Management of cardiac arrhythmias [sinus tachycardia, paroxysmal tachycardia, supraventricular and ventricular extrasystoles, drug induced extrasystoles (digitalis), atrial flutter and fibrillation - to slow the ventricular rate].
- Functional hyperadrenergic cardiac disturbances (hyperkinetic heart syndrome, neurocirculatory asthenia).